Trademark Overview
On Monday, July 15, 2024, a trademark application was filed for MACH-1 with the United States Patent and Trademark Office. The USPTO has given the MACH-1 trademark a serial number of 98648791. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 15, 2024. This trademark is owned by Orlance, Inc.. The MACH-1 trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; pharmaceutical preparations and substances for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes
Medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes
Research and development of vaccines; research and development of medicines; medical research; scientific research; clinical research; all in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy